Forte Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $6 | $6 |
Gross Profit | -10 | -9 | -6 |
EBITDA | -12,808 | -7,795 | -6,375 |
EBIT | -12,818 | -7,804 | -6,381 |
Net Income | -12,511 | -7,420 | -5,872 |
Net Change In Cash | 0 | 6 | 6 |
Free Cash Flow | -5,936 | -6,673 | -8,986 |
Cash | 24,498 | 10,635 | 11,961 |
Basic Shares | 1,845 | 1,843 | 36,335 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -9 | -36 | -54 | |
EBITDA | -32,476 | -13,896 | -21,450 | -46,433 |
EBIT | -32,485 | -13,896 | -21,486 | -46,487 |
Net Income | -31,476 | -13,862 | -21,708 | -78,544 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -28,794 | -8,185 | -16,677 | -18,423 |
Cash | 11,961 | 41,100 | 42,044 | 58,765 |
Basic Shares | 1,262 | 695 | 558 | 294 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$4.54 |
2024-06-30 | -$0.27 |
2024-03-31 | -$0.16 |
2023-12-31 | -$0.19 |
